Berko, Ablan
Berko, Ablan was paid $27K by Medicaid between Mar 2022 and Aug 2022, across 3 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoBERKO, ABLAN
CLINTON, MA 01510
CLINTON, MA 01510
33aNPI1053749812assigned 10/14/2013
33bProvider typeChild & Adolescent Psychiatric/Mental Health Registered Nurse
28Total paid$27K
24GClaims518
24DCodes billed3
24AFirst – last monthMar 2022 – Aug 2022
Compared with peers
Next to other Child & Adolescent Psychiatric/Mental Health Registered Nurse providers in Massachusetts
Rank by total paid#4 of 7
Median peer was paid$27K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 518 | $27K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 225 | 162 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 27% | 225 | 161 | $7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 16% | 68 | 63 | $4K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.